logo
  

First American Financial To Buy Interthinx For $155 Mln - Quick Facts

First American Financial Corp. (FAF), a provider of title insurance, settlement services and risk solutions to participants in real estate transactions, Thursday announced the signing of an agreement with Verisk Analytics, Inc. (VRSK) to acquire Interthinx, Inc., a provider of loan quality analytics, decision support tools and loan review services for the mortgage industry.

The purchase price is $155 million and the transaction is expected to close by March 31. The deal is estimated to be accretive to First American's 2014 earnings.

Established in 1996, Interthinx provides solutions to help clients minimize risk, increase operational efficiencies, satisfy regulatory requirements, manage data verification and ensure compliance.

The company is best known for FraudGUARD, its market-leading mortgage fraud analytics product.

BofA Merrill Lynch is acting as financial advisor, and McGuireWoods LLP as legal advisor, to First American in connection with the transaction.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT